EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence
EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence
About this item
Full title
EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence
Publisher
New York: PR Newswire Association LLC
Journal title
PR Newswire Europe (French), 2022
Language
French
Formats
Publication information
Publisher
New York: PR Newswire Association LLC
More information
Alternative Titles
Full title
EditForce et Mitsubishi Tanabe Pharma concluent un accord de licence
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2684871626
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2684871626
How to access this item
Log in as a Library member